Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-13044 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10021 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10041 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-10043 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10051 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10034 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10322 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10043 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10343 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0688 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-761 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-761 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 |
filingDate |
2018-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2020-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2020-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-102122117-B1 |
titleOfInvention |
A Cell Line for Producing Adenovirus having limitedautoreplication capability and A Method of the same |
abstract |
The present invention is a non-replicating adenovirus-producing cell line; And a method for manufacturing the same, more specifically, the E1 protein of adenovirus; And it relates to a cell line for producing adenovirus lacking replication ability by expressing any one or more selected from E1A protein or E1B protein and a method for manufacturing the same. In addition, the cell line of the present invention is adenovirus E1 protein; And E1A protein or E1B protein. |
priorityDate |
2017-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |